{"id":"https://openalex.org/W4362495467","doi":"https://doi.org/10.1158/1535-7163.c.6536584","title":"Data from Combined Pan-RAF and MEK Inhibition Overcomes Multiple Resistance Mechanisms to Selective RAF Inhibitors","display_name":"Data from Combined Pan-RAF and MEK Inhibition Overcomes Multiple Resistance Mechanisms to Selective RAF Inhibitors","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362495467","doi":"https://doi.org/10.1158/1535-7163.c.6536584"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.c.6536584","doi":"https://doi.org/10.1158/1535-7163.c.6536584","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.c.6536584","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1535-7163.c.6536584","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034616567","display_name":"Steven R. Whittaker","orcid":"https://orcid.org/0000-0001-9062-7947","observed_orcids":["https://orcid.org/0000-0001-9062-7947"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steven R. Whittaker","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060190177","display_name":"Glenn S. Cowley","orcid":"https://orcid.org/0000-0002-0526-0616","observed_orcids":["https://orcid.org/0000-0002-0526-0616"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Glenn S. Cowley","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109269558","display_name":"Steve Wagner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steve Wagner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112904471","display_name":"Flora Luo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Flora Luo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086771961","display_name":"David E. Root","orcid":"https://orcid.org/0000-0001-5122-861X","observed_orcids":["https://orcid.org/0000-0001-5122-861X","https://orcid.org/0000-0003-0096-4830"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David E. Root","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5055048393","display_name":"Levi A. Garraway","orcid":"https://orcid.org/0000-0003-3739-0471","observed_orcids":["https://orcid.org/0000-0003-3739-0471"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Levi A. Garraway","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pan-raf-inhibitor","display_name":"pan-RAF inhibitor","score":0.8109999895095825},{"id":"https://openalex.org/keywords/mek-inhibitors","display_name":"MEK inhibitors","score":0.9919999837875366},{"id":"https://openalex.org/keywords/raf-inhibitor-resistance","display_name":"RAF inhibitor resistance","score":0.8479999899864197},{"id":"https://openalex.org/keywords/braf-mutant-melanoma","display_name":"BRAF-mutant melanoma","score":0.8960000276565552},{"id":"https://openalex.org/keywords/braf-mutant-colorectal-cancer","display_name":"BRAF-mutant colorectal cancer","score":0.9990000128746033},{"id":"https://openalex.org/keywords/raf-1","display_name":"Raf-1","score":0.843999981880188},{"id":"https://openalex.org/keywords/plx4720","display_name":"PLX4720","score":0.9179999828338623},{"id":"https://openalex.org/keywords/dabrafenib","display_name":"dabrafenib","score":0.9639999866485596},{"id":"https://openalex.org/keywords/mapk-signaling","display_name":"MAPK signaling","score":0.8309999704360962},{"id":"https://openalex.org/keywords/kras-mutation","display_name":"KRAS mutation","score":0.9330000281333923},{"id":"https://openalex.org/keywords/receptor-tyrosine-kinase-signaling","display_name":"receptor tyrosine kinase signaling","score":0.7009999752044678},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5320000052452087},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.6200000047683716},{"id":"https://openalex.org/keywords/enhancer-screen","display_name":"enhancer screen","score":0.8130000233650208}],"concepts":[{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.7092939019203186},{"id":"https://openalex.org/C2781249067","wikidata":"https://www.wikidata.org/wiki/Q17142288","display_name":"MEK inhibitor","level":4,"score":0.7070086002349854},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6131311058998108},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.5758523941040039},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.4819374084472656},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.41211074590682983},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.39671576023101807},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3725411295890808},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.3198475241661072},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2802228629589081},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.16668403148651123},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.09294438362121582}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1535-7163.c.6536584","doi":"https://doi.org/10.1158/1535-7163.c.6536584","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.c.6536584","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1535-7163.c.6536584.v1","doi":"https://doi.org/10.1158/1535-7163.c.6536584.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.c.6536584.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.c.6536584","doi":"https://doi.org/10.1158/1535-7163.c.6536584","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.c.6536584","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1852944023","https://openalex.org/W2405035841","https://openalex.org/W2315978372","https://openalex.org/W4243460376","https://openalex.org/W1527410143","https://openalex.org/W2091334045","https://openalex.org/W2499892494","https://openalex.org/W2032867638","https://openalex.org/W1980608547","https://openalex.org/W1576318301"],"abstract_inverted_index":{"Abstract":[0],"RAF":[1,34,44,74,140],"and":[2,111,119,185,200,206,216,226],"MEK":[3,104,112,148,186,201,217],"inhibitors":[4,99,113,149,163],"are":[5],"effective":[6],"in":[7,12,31,100,117,168,173,189],"BRAF-mutant":[8,13],"melanoma":[9,118],"but":[10],"not":[11,151],"colorectal":[14,36,120],"cancer.":[15],"To":[16],"gain":[17],"additional":[18],"insights":[19],"into":[20],"this":[21],"difference,":[22],"we":[23],"performed":[24],"a":[25,32,85,103,165,220],"genome-scale":[26],"pooled":[27],"shRNA":[28],"enhancer":[29],"screen":[30],"BRAF-mutant,":[33],"inhibitor\u2013resistant":[35],"cancer":[37,121],"cell":[38,122],"line":[39],"exposed":[40],"to":[41,71,175,209],"the":[42,52,72,95,107,176,190],"selective":[43,73,139],"inhibitor":[45,75],"PLX4720.":[46],"We":[47],"identified":[48],"multiple":[49],"genes":[50],"along":[51],"receptor":[53],"tyrosine":[54],"kinase":[55,58],"(RTK)/mitogen-activated":[56],"protein":[57],"(MAPK)":[59],"signaling":[60],"axis":[61],"that,":[62],"when":[63],"suppressed,":[64],"either":[65],"genetically":[66],"or":[67,133,145],"pharmacologically,":[68],"sensitized":[69],"cells":[70],"through":[76],"sustained":[77],"inhibition":[78,158,187,202,218],"of":[79,88,97,109,138,159,192],"MAPK":[80],"signaling.":[81],"Strikingly,":[82],"CRAF":[83,160],"was":[84],"key":[86,166],"mediator":[87],"resistance":[89,208],"that":[90,157],"could":[91],"be":[92],"overcome":[93,204],"by":[94,161],"use":[96],"pan-RAF":[98,110,162,184,199,215],"combination":[101,108],"with":[102,124,147,180],"inhibitor.":[105],"Furthermore,":[106],"displayed":[114],"strong":[115],"synergy":[116],"lines":[123],"RAS-activating":[125],"events":[126],"such":[127,142,153],"as":[128,143,219],"RTK":[129],"activation,":[130],"KRAS":[131],"mutation,":[132],"NF1":[134],"loss-of-function":[135],"mutations.":[136],"Combinations":[137],"inhibitors,":[141],"PLX4720":[144],"dabrafenib,":[146],"did":[150],"incur":[152],"profound":[154],"synergy,":[155],"suggesting":[156],"plays":[164],"role":[167],"determining":[169],"cellular":[170],"response.":[171],"Importantly,":[172],"contrast":[174],"modest":[177],"activity":[178],"seen":[179],"single-agent":[181,210],"treatment,":[182],"dual":[183,214],"results":[188],"induction":[191],"apoptosis,":[193],"greatly":[194],"enhancing":[195],"efficacy.":[196],"Notably,":[197],"combined":[198],"can":[203],"intrinsic":[205],"acquired":[207],"RAF/MEK":[211],"inhibition,":[212],"supporting":[213],"novel":[221],"therapeutic":[222],"strategy":[223],"for":[224],"BRAF-":[225],"KRAS-mutant":[227],"cancers.":[228],"Mol":[229],"Cancer":[230],"Ther;":[231],"14(12);":[232],"2700\u201311.":[233],"\u00a92015":[234],"AACR.":[235]},"counts_by_year":[],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2023-04-05T00:00:00"}